Display Settings:

Format

Send to:

Choose Destination
Nutr Rev. 2005 Aug;63(8):290-3.

Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?

Author information

  • 1Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology and Laboratory Medicine, University of California-Davis Medical Center, Sacramento, USA.

Abstract

Oxidative stress and inflammation play a crucial role in atherosclerosis. However, prospective clinical trials of dietary antioxidants with anti-inflammatory properties, such as alpha-tocopherol (AT), have not yielded positive results. AT supplementation decreases gamma-tocopherol (GT) levels. GT is an antioxidant with potent anti-inflammatory activity, and plasma GT levels are inversely associated with cardiovascular diseases. Thus, studies using pure GT, alone or in conjunction with AT, will elucidate its utility in cardiovascular disease prevention.

PMID:
16190316
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk